ARS Pharmaceuticals
SPRY
SPRY
73 hedge funds and large institutions have $425M invested in ARS Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 25 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
53.34% more ownership
Funds ownership: 85.77% → 139.11% (+53%)
20% more funds holding
Funds holding: 61 → 73 (+12)
Holders
73
Holding in Top 10
3
Calls
$6.79M
Puts
–
Top Buyers
| 1 | +$94.5M | |
| 2 | +$25.7M | |
| 3 | +$25.7M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$17.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.17M |
Top Sellers
| 1 | -$6.6M | |
| 2 | -$3.2M | |
| 3 | -$2.7M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.24M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.3M |